Explore
Validate
Learn
Western blot
ImmunohistochemistryAntibody data
- Antibody Data
- Antigen structure
- References [12]
- Comments [0]
- Validations
- Immunohistochemistry [2]
Submit
Validation data
Reference
Comment
Report error
- Product number
- GTX21316 - Provider product page
- Provider
- GeneTex
- Proper citation
- GeneTex Cat#GTX21316, RRID:AB_373276
- Product name
- VEGF antibody [VG1]
- Antibody type
- Monoclonal
- Reactivity
- Human, Mouse, Rat
- Host
- Mouse
Submitted references Selective IKK2 inhibitor IMD0354 disrupts NF-κB signaling to suppress corneal inflammation and angiogenesis.
Genome-wide expression differences in anti-Vegf and dexamethasone treatment of inflammatory angiogenesis in the rat cornea.
MiR-182 promotes proliferation and invasion and elevates the HIF-1α-VEGF-A axis in breast cancer cells by targeting FBXW7.
Factors regulating capillary remodeling in a reversible model of inflammatory corneal angiogenesis.
Aging disrupts cell subpopulation dynamics and diminishes the function of mesenchymal stem cells.
Antiangiogenic treatment diminishes renal injury and dysfunction via regulation of local AKT in early experimental diabetes.
Expression of pro- and anti-angiogenic isoforms of VEGF in the mouse model of oxygen-induced retinopathy.
DNA oxidative damage of neoplastic rat liver lesions.
Identification of microRNA-93 as a novel regulator of vascular endothelial growth factor in hyperglycemic conditions.
Anti-human vascular endothelial growth factor (VEGF) antibody selection for immunohistochemical staining of proliferating blood vessels.
Human CD34/CD90 ASCs are capable of growing as sphere clusters, producing high levels of VEGF and forming capillaries.
Expression of VEGF in routinely fixed material using a new monoclonal antibody VG1.
Lennikov A, Mirabelli P, Mukwaya A, Schaupper M, Thangavelu M, Lachota M, Ali Z, Jensen L, Lagali N
Angiogenesis 2018 May;21(2):267-285
Angiogenesis 2018 May;21(2):267-285
Genome-wide expression differences in anti-Vegf and dexamethasone treatment of inflammatory angiogenesis in the rat cornea.
Mirabelli P, Mukwaya A, Lennikov A, Xeroudaki M, Peebo B, Schaupper M, Lagali N
Scientific reports 2017 Aug 15;7(1):7616
Scientific reports 2017 Aug 15;7(1):7616
MiR-182 promotes proliferation and invasion and elevates the HIF-1α-VEGF-A axis in breast cancer cells by targeting FBXW7.
Chiang CH, Chu PY, Hou MF, Hung WC
American journal of cancer research 2016;6(8):1785-98
American journal of cancer research 2016;6(8):1785-98
Factors regulating capillary remodeling in a reversible model of inflammatory corneal angiogenesis.
Mukwaya A, Peebo B, Xeroudaki M, Ali Z, Lennikov A, Jensen L, Lagali N
Scientific reports 2016 Aug 26;6:32137
Scientific reports 2016 Aug 26;6:32137
Aging disrupts cell subpopulation dynamics and diminishes the function of mesenchymal stem cells.
Duscher D, Rennert RC, Januszyk M, Anghel E, Maan ZN, Whittam AJ, Perez MG, Kosaraju R, Hu MS, Walmsley GG, Atashroo D, Khong S, Butte AJ, Gurtner GC
Scientific reports 2014 Nov 21;4:7144
Scientific reports 2014 Nov 21;4:7144
Antiangiogenic treatment diminishes renal injury and dysfunction via regulation of local AKT in early experimental diabetes.
Bai X, Li X, Tian J, Zhou Z
PloS one 2014 Apr 23;9(4):e96117
PloS one 2014 Apr 23;9(4):e96117
Expression of pro- and anti-angiogenic isoforms of VEGF in the mouse model of oxygen-induced retinopathy.
Zhao M, Shi X, Liang J, Miao Y, Xie W, Zhang Y, Li X
Experimental eye research 2011 Dec;93(6):921-6
Experimental eye research 2011 Dec;93(6):921-6
DNA oxidative damage of neoplastic rat liver lesions.
Marengo B, De Ciusis C, Ricciarelli R, Romano P, Passalacqua M, Marinari UM, Pronzato MA, Domenicotti C
Oncology reports 2010 May;23(5):1241-6
Oncology reports 2010 May;23(5):1241-6
Identification of microRNA-93 as a novel regulator of vascular endothelial growth factor in hyperglycemic conditions.
Long J, Wang Y, Wang W, Chang BH, Danesh FR
The Journal of biological chemistry 2010 Jul 23;285(30):23457-65
The Journal of biological chemistry 2010 Jul 23;285(30):23457-65
Anti-human vascular endothelial growth factor (VEGF) antibody selection for immunohistochemical staining of proliferating blood vessels.
van der Loos CM, Meijer-Jorna LB, Broekmans ME, Ploegmakers HP, Teeling P, de Boer OJ, van der Wal AC
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 2010 Feb;58(2):109-18
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 2010 Feb;58(2):109-18
Human CD34/CD90 ASCs are capable of growing as sphere clusters, producing high levels of VEGF and forming capillaries.
De Francesco F, Tirino V, Desiderio V, Ferraro G, D'Andrea F, Giuliano M, Libondi G, Pirozzi G, De Rosa A, Papaccio G
PloS one 2009 Aug 6;4(8):e6537
PloS one 2009 Aug 6;4(8):e6537
Expression of VEGF in routinely fixed material using a new monoclonal antibody VG1.
Turley H, Scott PA, Watts VM, Bicknell R, Harris AL, Gatter KC
The Journal of pathology 1998 Nov;186(3):313-8
The Journal of pathology 1998 Nov;186(3):313-8
No comments: Submit comment
Supportive validation
- Submitted by
- GeneTex (provider)
- Main image
- Experimental details
- IHC Image using GTX21316 - Detection of VEGF by IHC in Human Angiosarcoma
- Submitted by
- GeneTex (provider)
- Main image
- Experimental details
- IHC-P analysis of human kidney using VEGF antibody [VG1].
